— Know what they know.
Not Investment Advice

GRAL NASDAQ

GRAIL, Inc.
1W: +9.8% 1M: +29.0% 3M: +35.1% YTD: -23.6% 1Y: +72.6%
$67.19
-0.67 (-0.99%)
 
Weekly Expected Move ±11.3%
$46 $53 $60 $66 $73
NASDAQ · Healthcare · Medical - Diagnostics & Research · Alpha Radar Buy · Power 64 · $2.9B mcap · 39M float · 2.49% daily turnover · Short 78% of daily vol

Revenue Segmentation

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$147M +17.2% ▲
Gross Profit
-$63M +19.8% ▲
Operating Income
-$534M +75.6% ▲
Net Income
-$408M +79.9% ▲
EPS (Diluted)
$-11.11 +82.5% ▲
EBITDA
-$378M +38.1% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$15M$56M$93M$126M$147M
YoY Growth+0.0%+280.2%+67.6%+34.9%+17.2%
Cost of Revenue$115M$172M$189M$204M$210M
Gross Profit-$100M-$116M-$96M-$78M-$63M
Gross Margin-684.4%-209.6%-102.7%-62.1%-42.5%
R&D Expenses$460M$330M$339M$322M$196M
SG&A Expenses$234M$296M$363M$368M$276M
Operating Expenses$1.2B$5.3B$1.4B$2.1B$472M
Operating Income-$1.3B-$5.4B-$1.5B-$2.2B-$534M
Operating Margin-8659.6%-9798.2%-1627.6%-1743.0%-363.0%
Interest Expense$0$0$0$0$0
Income Before Tax-$1.3B-$5.4B-$1.5B-$2.2B-$535M
Tax Expense-$17M-$42M-$42M-$135M-$126M
Net Income-$1.2B-$5.4B-$1.5B-$2.0B-$408M
Net Margin-8539.4%-9719.3%-1574.2%-1613.9%-277.5%
EPS (Diluted)$-40.18$-173.87$-47.20$-63.54$-11.11
EBITDA-$1.2B-$588M-$638M-$610M-$378M
Shares Outstanding31M31M31M32M37M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms